About Aethlon Medical (NASDAQ:AEMD)
Aethlon Medical, Inc., a medical device company, focuses on creating devices that address unmet medical needs in health and biodefense worldwide. The company is developing Aethlon Hemopurifier, a clinical-stage therapeutic device for the single-use removal of life-threatening viruses from the circulatory system of infected individuals. It is also involved in the development of exosome-based products to diagnose and monitor neurological disorders and cancer; and a therapeutic device to reduce the incidence of sepsis, a fatal bloodstream infection. The company was founded in 1991 and is based in San Diego, California.
Industry, Sector and Symbol
Industry Analytical instruments
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:AEMD
CUSIPN/A
Phone858-459-7800
Debt
Debt-to-Equity Ratio0.18%
Current Ratio17.03%
Quick Ratio17.03%
Price-To-Earnings
Trailing P/E Ratio-1.37
Forward P/E Ratio-2.69
P/E GrowthN/A
Sales & Book Value
Annual Sales$390,000.00
Price / Sales55.24
Cash FlowN/A
Price / CashN/A
Book Value$0.07 per share
Price / Book18.43
Profitability
EPS (Most Recent Fiscal Year)($0.94)
Net Income$-7,270,000.00
Net MarginsN/A
Return on Equity-569.13%
Return on Assets-265.51%
Miscellaneous
Employees7
Outstanding Shares16,700,000
Aethlon Medical (NASDAQ:AEMD) Frequently Asked Questions
What is Aethlon Medical's stock symbol?
Aethlon Medical trades on the NASDAQ under the ticker symbol "AEMD."
How were Aethlon Medical's earnings last quarter?
Aethlon Medical (NASDAQ:AEMD) announced its earnings results on Thursday, February, 1st. The medical equipment provider reported ($0.08) earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.12) by $0.04. The medical equipment provider earned $0.08 million during the quarter, compared to analysts' expectations of $0.08 million. View Aethlon Medical's Earnings History.
What price target have analysts set for AEMD?
1 analysts have issued 1 year target prices for Aethlon Medical's stock. Their forecasts range from $3.00 to $3.00. On average, they expect Aethlon Medical's share price to reach $3.00 in the next year. View Analyst Ratings for Aethlon Medical.
Who are some of Aethlon Medical's key competitors?
Some companies that are related to Aethlon Medical include AzurRx BioPharma (AZRX), Vivus (VVUS), Caladrius Biosciences (CLBS), Pure Bioscience (PURE), Proteon Therapeutics (PRTO), Omnicomm Systems (OMCM), IntelGenx Technologies (IGXT), Presbia (LENS), Celsion (CLSN), ANGLE (AGL), Edge Therapeutics (EDGE), Capricor Therapeutics (CAPR), ReNeuron (RNUGF), Vaxart (VXRT), Evoke Pharma (EVOK), Cellect Biotechnology (APOP), Lipocine (LPCN) and Soleno Therapeutics (SLNO).
Who are Aethlon Medical's key executives?
Aethlon Medical's management team includes the folowing people:
- Mr. James A. Joyce, Founder, CEO, Sec. & Director (Age 56)
- Mr. Rodney S. Kenley, Pres & Director (Age 68)
- Mr. James B. Frakes, CFO & Sr. VP of Fin., CHIEF ACCOUNTING OFFICER (Age 61)
- Dr. Richard H. Tullis, Consultant (Age 73)
- Dr. Annette Marleau Ph.D., Director of Research (Age 43)
Has Aethlon Medical been receiving favorable news coverage?
News articles about AEMD stock have been trending somewhat negative recently, according to Accern Sentiment Analysis. The research group rates the sentiment of press coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Aethlon Medical earned a news sentiment score of -0.01 on Accern's scale. They also assigned media stories about the medical equipment provider an impact score of 47.80 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next few days.
How do I buy shares of Aethlon Medical?
Shares of AEMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Aethlon Medical's stock price today?
One share of AEMD stock can currently be purchased for approximately $1.29.
How big of a company is Aethlon Medical?
Aethlon Medical has a market capitalization of $22.55 million and generates $390,000.00 in revenue each year. The medical equipment provider earns $-7,270,000.00 in net income (profit) each year or ($0.94) on an earnings per share basis. Aethlon Medical employs 7 workers across the globe.
How can I contact Aethlon Medical?
Aethlon Medical's mailing address is 9635 GRANITE RIDGE DRIVE SUITE 100, SAN DIEGO CA, 92123. The medical equipment provider can be reached via phone at 858-459-7800 or via email at [email protected]
MarketBeat Community Rating for Aethlon Medical (AEMD)
MarketBeat's community ratings are surveys of what our community members think about Aethlon Medical and other stocks. Vote "Outperform" if you believe AEMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AEMD will underperform the S&P 500 over the long term. You may vote once every thirty days.
Aethlon Medical (NASDAQ:AEMD) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
1 Wall Street analysts have issued ratings and price targets for Aethlon Medical in the last 12 months. Their average twelve-month price target is $3.00, suggesting that the stock has a possible upside of 132.56%. The high price target for AEMD is $3.00 and the low price target for AEMD is $3.00. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | N/A |
| Consensus Rating Score: | 3.00 | 3.00 | 3.00 | N/A |
| Ratings Breakdown: | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $3.00 | $3.00 | $3.00 | N/A |
| Price Target Upside: | 132.56% upside | 209.28% upside | 209.28% upside | N/A |
Aethlon Medical (NASDAQ:AEMD) Consensus Price Target History
Aethlon Medical (NASDAQ:AEMD) Analyst Ratings History
Show:
| Date | Brokerage | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 11/20/2017 | HC Wainwright | Initiated Coverage | Buy -> Buy | $3.00 | N/A |  |
(Data available from 4/20/2016 forward)
Aethlon Medical (NASDAQ:AEMD) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Aethlon Medical (NASDAQ AEMD) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 6.58%
Institutional Ownership Percentage: 5.14%
Aethlon Medical (NASDAQ AEMD) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
(Data available from 1/1/2013 forward)
Aethlon Medical (NASDAQ AEMD) News Headlines
| Source: |
|
Aethlon Medical (NASDAQ:AEMD) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Aethlon Medical (NASDAQ:AEMD) Income Statement, Balance Sheet and Cash Flow Statement
Aethlon Medical (NASDAQ AEMD) Stock Chart for Friday, April, 20, 2018
Loading chart…
